SavedAdd your journal

Journals / Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi / 2019 / Volume: 4 Issue: 3

A RARE LOWER EXTREMITY SOFT TISSUE SARCOMA WITH INCREASED FDG UPTAKE ON FDG PET/CT: A CASE OF MYXOID LIPOSARCOMA

FDG PET/BT’DE ARTMIŞ FDG TUTULUMU GÖSTEREN NADİR BİR ALT EKSTREMİTE YUMUŞAK DOKU SARKOMU: MİKSOİD LİPOSARKOM OLGUSU

Sevin Coşar Ayaz(Mersin Şehir Eğitim ve Araştırma Hastanesi, Nükleer Tıp Kliniği; Toros Üniversitesi Meslek Yüksekokulu, Tıbbi Görüntüleme Teknikleri Bölümü, Mersin)
Hasanali Durmaz(Sağlık Bilimleri Üniversitesi, Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hastanesi, Radyoloji Kliniği, Ankara)0000-0003-3230-9240
Mehmet Ercüment Döğen(Mersin Şehir Eğitim ve Araştırma Hastanesi, Radyoloji Kliniği, Mersin)0000-0002-5414-2771
Pages
—
Publication Date
2019-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

FDG PET/CT was found to be useful in staging of our case with myxoid liposarcoma because of its contribution to metastasis evaluation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Abstract A 45 years old man with the diagnosis of myxoid liposarcoma in posterior part of his right thigh underwent [18F]-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) for staging purpose.
📊
Key Findings & Data:In posterior of the middle and distal 1/3 parts of the right femur, a soft tissue mass measuring 105x92 mm with lobulated contours pushing neighboring muscles was detected which included septated myxoid-cystic and fat components on CT images and showed heterogeneously increased FDG uptake ( SUVmax: 3.35) on FDG - PET / CT fusion images.
💡
Conclusion & Impact:FDG PET/CT was found to be useful in staging of our case with myxoid liposarcoma because of its contribution to metastasis evaluation.
🔬Design:Case Report
📍Scope:Comprehensive Sample
⚙️Variables:Fluorodeoxyglucose F18 · positron-emission tomography/computed tomography · sarcoma

Abstract

Abstract A 45 years old man with the diagnosis of myxoid liposarcoma in posterior part of his right thigh underwent [18F]-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) for staging purpose. In posterior of the middle and distal 1/3 parts of the right femur, a soft tissue mass measuring 105x92 mm with lobulated contours pushing neighboring muscles was detected which included septated myxoid-cystic and fat components on CT images and showed heterogeneously increased FDG uptake ( SUVmax: 3.35) on FDG - PET / CT fusion images. No evidence of metastasis could be detected on other FDG PET/CT images and the tumor was removed totally after imaging. FDG PET/CT is being used for grading purpose in soft tissue sarcomas and plays important role in determining the site for biopsy. FDG PET/CT was found to be useful in staging of our case with myxoid liposarcoma because of its contribution to metastasis evaluation.

Özet

Sağ uyluk posteriorunda miksoid liposarkom tanılı 45 yaşında erkek olgunun evreleme amaçlı [18F]-2-floro-2-deoksi-D-glukoz (FDG) pozitron emisyon tomografisi (PET)/bilgisayarlı tomografi (BT) görüntülemesi yapılmıştır. Olgunun sağ uyluk orta ve distal 1/3 kesimi posteriorunda yaklaşık 105x92 mm boyutlarda, lobüle konturlu, komşu adale yapılarını iten, BT’de septalarla ayrılmış miksoid-kistik ve yağ bileşenleri içeren, füzyon görüntülerde ise heterojen artmış FDG tutulumu gösteren ( SUVmaks: 3.35) yumuşak doku kitlesi saptanmıştır. Diğer FDG PET/BT kesitlerinde metastaz tespit edilememiş olup, g örüntüleme sonrasında kitle total olarak çıkarılmıştır. FDG PET/BT yumuşak doku sarkomlarında grade belirlemede kullanılmakta olup, biyopsinin nereden alınacağının saptanmasında da önemli rol oynamaktadır. FDG PET/BT, alt ekstremitesinde miksoid liposarkom kitlesi bulunan olgumuzun evrelemesinde, metastaz değerlendirmesine katkı sağladığı için yararlı bulunmuştur.

🔖

Cite This Article

Ayaz, S. C., Durmaz, H., Döğen, M. E. (2019). A RARE LOWER EXTREMITY SOFT TISSUE SARCOMA WITH INCREASED FDG UPTAKE ON FDG PET/CT: A CASE OF MYXOID LIPOSARCOMA. Cumhuriyet Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi, Volume: 4 Issue: 3. https://ajindex.com/articles/1471449

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Loubignac F, Bourtoul C, Chapel F. (2009). Myxoid liposarcoma: a rare soft-tissue tumor with a misleading benign appearance. World J Surg Oncol; 7:42.
  2. Nieweg OE, Pruim J, Hoekstra HJ, Paans AM, Vaalburg W, Oldhoff J, Schraffordt Koops H. (1994). Positron emission tomography with fluorine-18-fluorodeoxyglucose for the evaluation of therapeutic isolated regional limb perfusion in a patient with soft-tissue sarcoma. J Nucl Med; 35(1):90–2.
  3. Hicks RJ. (2005). Functional imaging techniques for evaluation of sarcomas. Cancer Imaging; 5(1):58–65.
  4. Townsend DW, Beyer T, Blodgett TM. (2003). PET/CT scanners: a hardware approach to image fusion. Semin Nucl Med; 33:193–204.
  5. Hicks RJ, Toner GC, Choong PF. (2005). Clinical applications of molecular imaging in sarcoma evaluation. Cancer Imaging; 5(1):66–72.
  6. Eary JF, O'Sullivan F, Powitan Y, Chandhury KR, Vernon C, Bruckner JD, Conrad EU. (2002). Sarcoma tumor FDG uptake measured by PET and patient outcome: a retrospective analysis. Eur J Nucl Med Mol Imaging; 29:1149–54.
  7. Sambri A, Bianchi G, Longhi A, Righi A, Donati DM, Nanni C, Fanti S, Errani C. (2019). The role of 18F-FDG PET/CT in soft tissue sarcoma. Nucl Med Commun; 40(6):626−31.
  8. Knebel C, Lenze U, Pohlig F, Lenze F, Harrasser N, Suren C, Breitenbach J, Rechl H, Eisenhart-Rothe R, Mühlhofer HML. (2017). Prognostic factors and outcome of liposarcoma patients: a retrospective evaluation over 15 years. BMC Cancer; 17:410.
  9. Dalal KM, Antonescu CR, Singer S. (2008). Diagnosis and management of lipomatous tumors. J Surg Oncol; 97(4):298–313.